Results 101 to 110 of about 4,959 (213)

In vitro antitumor activity of silybin nanosuspension in PC-3 cells

, 2011
The present study aims to evaluate the antitumor activity of silybin nanosuspension on human prostatic carcinoma PC-3 cell line in vitro. Silybin nanosuspension was prepared by the high pressure homogenization (HPH) method.
Lejiao Jia, Qiang Zhang, Liu, Zhaoping, Duan, Cunxian, Wang, Feihu, Zhang, Qiang, Feihu Wang, Guangpu Liu, Zhang, Dianrui, Jia, Lejiao, Liu, Guangpu, Leilei Hao, Dandan Zheng, Yue Liu, Dianrui Zhang, Cunxian Duan, Hao, Leilei, Liu, Yue, Zheng, Dandan, Zhaoping Liu, Yancai Wang, Wang, Yancai   +21 more
core   +1 more source

Formulation And Development Of Nanosuspension As An Alternative Approach For Solubility And Dissolution Enhancement Of Aceclofenac [PDF]

, 2018
Main objectives to develop Aceclofenac Nanosuspension are to enhance solubility and dissolution rate of poorly soluble Drug (aceclofenac), substantially leading to its bioavailability enhancement and Improvement of aqueous and saturation solubility in ...
Patel, Harshil M, Patel, Urvashi B., Shah, Chainesh, Akbari, Bhavesh   +3 more
core  

Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension

, 2010
The mechanism for anti-tumor activity of oridonin (ORI) nanosuspension, prepared by the high pressure homogenization method, was studied using MCF-7 human breast carcinoma cells in vitro.
Qi, Xiao-Li, Hai-Yan Lou, Qiang Zhang, Lou, Hai-Yan, Zhang, Qiang, Wang, Yan-Cai, Wang, Fei-Hu, Tian, Ke-Li, Duan, Cun-Xian, Fei-Hu Wang, Cun-Xian Duan, Yue Liu, Xiao-Li Qi, Feng, Fei-Fei, Liu, Yue, Zhang, Dian-Rui, Ke-Li Tian, Yan-Cai Wang, Fei-Fei Feng, Le-Jiao Jia, Jia, Le-Jiao, Dian-Rui Zhang   +21 more
core   +1 more source

A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects

, 2018
Qi Li,1 Fen Chen,2 Yun Liu,1 Shihui Yu,1 Xiumei Gai,1 Mingzhu Ye,1 Xinggang Yang,1 Weisan Pan1 1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People’s Republic of China; 2Key Laboratory of ...
Ye M, Yang X, Liu Y, Gai X, Pan W, Yu S, Chen F, Li Q   +7 more
core  

FORMULATION AND EVALUATION OF GLICLAZIDE NANOSUSPENSION FOR SOLUBILITY AND DISSOLUTION ENHANCEMENT

Objectives: The present aim of this research was to develop and characterize a gliclazide-containing nanosuspension using various polymers. Methods: There are many approaches to enhance the low solubility and dissolution rate of medications and drug ...
RAVINDRA M HANWATE, RAMENANI HARI BABU
core   +1 more source

Nanosuspension in Drug Delivery

The science of nanotechnology studies processes at the molecular level and at sizes smaller than a nanometer. The term “nano” describes the particle size range of 1–1000 nm. Nanotechnology includes nanosuspensions. An item of pharmaceutical A very finely colloid, biphasic, dispersed solid drug particle in an aqueous vehicle, with a size below 1 μm ...
openaire   +1 more source

FORMULATION DEVELOPMENT AND EVALUATION OF PALIPERIDONE NANOSUSPENSION FOR SOLUBILITY ENHANCEMENT

Objective: The main objective of this work is to develop a nanosuspension formulation of paliperidone to overcome its low solubility and bioavailability issues.
JADHAV, SHIVRAJ POPAT, GUPTA, TAPASVI, DHAKAD, PRASHANT KUMAR, GILHOTRA, RITU   +3 more
core   +1 more source

Formulation and characterization of nano biopesticides via nanosuspension technology and its packaging designs. [PDF]

Discov Nano
Niu X, Shen Y, Wang P, Rasheed K.
europepmc   +1 more source

Oral cyclosporine a nanosuspension for improved immunosuppressive efficacy: In vivo cytokine profiling in rats.

Background: Cyclosporine A (CycA) is a cornerstone immunosuppressant in transplantation, but its poor solubility and variable bioavailability limit therapeutic efficacy.
Pinar, Sıla Gülbağ, Tan, ÇAĞMAN, Çelebi, Nevin, Gülbağ Pınar, Sıla   +3 more
core   +1 more source

Curcumin-Dragon's blood-chitosan nanosuspension for dual forensic detection. [PDF]

Sci Rep
Fatease AA, Nagashubha B, Hani U, Alamri AH, Maccha KS, Safhi AY, AlQahtani F, Mallam SL, Vallabhi S, Shaik YB, Chakali V.   +10 more
europepmc   +1 more source